Table 7.
Group | Glucose-6-phosphatase (n moles of Pi liberated/min/mg protein) | Fructose-1,6-diphosphatase (n moles of Pi liberated/min/mg protein) |
---|---|---|
C | 44.968 ± 4.26 | 33.84 ± 3.51 |
A | 101.94 ± 6.79 | 347.45 ± 11.54 |
A + M100 | 79.73 ± 3.27∗ | 62.96 ± 8.18∗ |
A + M200 | 61.98 ± 3.06∗ | 44.18 ± 2.24∗ |
A + M500 | 49.76 ± 3.46∗ | 35.04 ± 1.72∗ |
A + G500 | 74.74 ± 8.89∗ | 70.04 ± 7.69∗ |
A + G750 | 56.44 ± 3.78∗ | 50.936 ± 5.54∗ |
A + G1000 | 46.12 ± 3.072∗ | 40.146 ± 2.40∗ |
M100 | 47.052 ± 3.51 | 32.458 ± 3.45 |
M200 | 42.516 ± 2.26 | 30.62 ± 3.12 |
M500 | 48.56 ± 2.35 | 30 ± 0.911 |
G 500 | 45.84 ± 2.32 | 33.52 ± 1.85 |
G 750 | 44.652 ± 3.28 | 31.64 ± 4.05 |
G 1000 | 50.22 ± 3.39 | 31.58 ± 2.03 |
∗ p < 0.05 indicates a significant difference from the disease group (C = control group, A = alloxan-treated group, M = metformin, A + M = alloxan + metformin, A + G = alloxan + Gynura, and G = G. procumbens).